第一医药: 上海第一医药股份有限公司2024年年度股东大会决议的公告

Meeting Overview - The shareholders' meeting of Shanghai First Pharmaceutical Co., Ltd. was held on June 20, 2025, at the company's office in Shanghai [1] - The meeting was presided over by Chairman Zhang Haibo and utilized a combination of on-site and online voting methods, complying with relevant laws and regulations [1][3] - A total of 50.2559% of the shares were represented at the meeting [1] Voting Results - A total of 12 proposals were reviewed during the meeting, with proposals 1-7, 9-12 passing by a simple majority, while proposal 8, a special resolution, passed with over two-thirds of the votes [3] - The voting results for the proposals showed a high level of agreement among shareholders, with the majority of votes for each proposal exceeding 99% [2][3] - For example, proposal 1 received 111,862,784 votes in favor, representing 99.7759% of the votes [1][2] Legal Compliance - The meeting's procedures, attendance, and voting processes were confirmed to be in accordance with the Company Law, Securities Law, and other relevant regulations [3][4] - The legal opinions provided by the attending lawyers confirmed the legality and validity of the resolutions passed during the meeting [3][4]